| （高级）医药代表 /（资深）产品专员 |
Shantou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Bir 18, 2024 |
| （高级）医药代表 /（资深）产品专员 |
Shantou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Bir 06, 2024 |
| （高级）医药代表 /（资深）产品专员 |
Shantou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Bir 18, 2024 |
| （高级）医药代表 /（资深）产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
Spa 09, 2024 |
| Senior Marketing Manager |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Marketing |
Gegužė 15, 2024 |
| Head of Customer Strategy & Operations |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Marketing |
Rug 03, 2024 |
| Center Operation Manager |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Marketing |
Rug 03, 2024 |
| Clinical Development Medical Manager |
Shanghai (Shanghai) |
China |
Development |
Innovative Medicines |
Research & Development |
Gegužė 30, 2024 |
| Principal Biostatistician |
Shanghai (Shanghai) |
China |
Development |
Innovative Medicines |
Research & Development |
Bir 20, 2024 |
| （高级）地区经理 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
Bir 21, 2024 |
| （高级）地区经理 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
Bir 21, 2024 |
| Sr. Manager DDIT GF Sol.Del. China |
Shanghai (Shanghai) |
China |
Operations |
CTS |
Technology Transformation |
Rug 03, 2024 |
| Senior Brand Manager |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Marketing |
Bal 29, 2024 |
| （高级）医药代表 /（资深）产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
Spa 18, 2024 |
| Senior Brand Manager |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Marketing |
Bal 16, 2024 |
| MSL Manager, RLT |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Research & Development |
Bal 18, 2024 |
| Associate Clinical Development Medical Director |
Shanghai (Shanghai) |
China |
Development |
Innovative Medicines |
Research & Development |
Rugp 22, 2024 |
| Clinical Development Medical Manager |
Shanghai (Shanghai) |
China |
Development |
Innovative Medicines |
Research & Development |
Lie 29, 2024 |
| Senior Legal Counsel |
Shanghai (Shanghai) |
China |
Legal |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
Lie 02, 2024 |
| Medical Advisor |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Research & Development |
Lie 15, 2024 |
| RLT HCS & Partnerships Head |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Marketing |
Rug 03, 2024 |
| Sr Manager/Manager-Monitoring |
Shanghai (Shanghai) |
China |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
Lie 18, 2024 |
| PMO, Corporate |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
BD&L & Strategic Planning |
Rugp 08, 2024 |
| PMO, CRM&IPA |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
BD&L & Strategic Planning |
Rugp 08, 2024 |
| （高级）地区经理 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
Bir 21, 2024 |
| （高级）医药代表 /（资深）产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
Spa 18, 2024 |
| （高级）地区经理 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
Bir 21, 2024 |
| （高级）医药代表 /（资深）产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
Spa 18, 2024 |
| （高级）地区经理 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
Bir 21, 2024 |
| Senior Accountant, Tax |
Shanghai (Shanghai) |
China |
Finance |
Corporate |
Audit & Finance |
Rugp 29, 2024 |
| （高级）医药代表 /（资深）产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
Spa 18, 2024 |
| （高级）地区经理 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
Bir 21, 2024 |
| （高级）医药代表 /（资深）产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
Spa 18, 2024 |
| （高级）地区经理 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
Bir 21, 2024 |
| Head DPDAI China |
Shanghai (Shanghai) |
China |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
Spa 14, 2024 |
| （高级）医药代表 /（资深）产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
Spa 18, 2024 |
| （高级）医药代表 /（资深）产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
Spa 18, 2024 |
| （高级）地区经理 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
Bir 21, 2024 |
| （高级）医药代表 /（资深）产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
Spa 18, 2024 |
| （高级）地区经理 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
Bir 21, 2024 |
| （高级）地区经理 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
Bir 21, 2024 |
| （高级）医药代表 /（资深）产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
Spa 18, 2024 |
| （高级）医药代表 /（资深）产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
Spa 18, 2024 |
| （高级）大区经理 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
Spa 17, 2024 |
| Medical Advisor, Ophtha |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Research & Development |
Spa 18, 2024 |
| Medical Advisor, HEMA |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Research & Development |
Spa 18, 2024 |
| （高级）医药代表 /（资深）产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
Bal 29, 2024 |
| MSL Manager - Hematology |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Research & Development |
Gegužė 14, 2024 |
| P&O Manager,People Partner |
Shanghai (Shanghai) |
China |
People & Organization |
Innovative Medicines |
Human Resources |
Rug 03, 2024 |
| （高级）地区经理 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
Bir 21, 2024 |